These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1976733)

  • 1. Molecular basis of polymorphisms of human complement component C3.
    Botto M; Fong KY; So AK; Koch C; Walport MJ
    J Exp Med; 1990 Oct; 172(4):1011-7. PubMed ID: 1976733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha-chain of the complement component, C3.
    Poznansky MC; Clissold PM; Lachmann PJ
    J Immunol; 1989 Aug; 143(4):1254-8. PubMed ID: 2473125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of C3 allotypes in patients with nephritic factor.
    Finn JE; Mathieson PW
    Clin Exp Immunol; 1993 Mar; 91(3):410-4. PubMed ID: 8443964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele.
    Wong WW; Cahill JM; Rosen MD; Kennedy CA; Bonaccio ET; Morris MJ; Wilson JG; Klickstein LB; Fearon DT
    J Exp Med; 1989 Mar; 169(3):847-63. PubMed ID: 2564414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of C3 allotypes in Chinese patients with immunoglobulin A nephropathy.
    Finn JE; Li PK; Lai KN; Mathieson PW
    Am J Kidney Dis; 1994 Apr; 23(4):543-6. PubMed ID: 8154490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization and functional significance of a polymorphic determinant in the third component of human complement.
    Behrendt N; Hansen OC; Ploug M; Barkholt V; Koch C
    Mol Immunol; 1987 Oct; 24(10):1097-103. PubMed ID: 2446123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement component C3: molecular basis of the C3*S025 variant and evidence for molecular heterogeneity of other variants.
    Höhler T; Botto M; Rittner C; Schneider PM; Meyer zum Büschenfelde KH
    Hum Genet; 1995 Nov; 96(5):539-41. PubMed ID: 8530000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of multiple restriction fragment length polymorphisms of the gene for the human complement receptor type I. Duplication of genomic sequences occurs in association with a high molecular mass receptor allotype.
    Wong WW; Kennedy CA; Bonaccio ET; Wilson JG; Klickstein LB; Weis JH; Fearon DT
    J Exp Med; 1986 Nov; 164(5):1531-46. PubMed ID: 2877046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis is not caused by a defect in the gene coding for human complement C3.
    Davies KE; Gilliam TC; Williamson R
    Mol Biol Med; 1983 Sep; 1(2):185-90. PubMed ID: 6094950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement C3 gene polymorphism in renal transplantation (an Iranian experience).
    Bazyar N; Azarpira N; Khatami SR; Galehdari H; Salahi H
    Gene; 2012 May; 498(2):254-8. PubMed ID: 22361228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of five apolipoprotein B gene polymorphisms in noncoding regions.
    Huang LS; Ripps ME; Breslow JL
    J Lipid Res; 1990 Jan; 31(1):71-7. PubMed ID: 1968951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of human complement component C6: an amino acid substitution (Glu/Ala) within the second thrombospondin repeat differentiates between the two common allotypes C6 A and C6 B.
    Dewald G; Nöthen MM; Cichon S
    Biochem Biophys Res Commun; 1993 Jul; 194(1):458-64. PubMed ID: 8101442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous hereditary C3 deficiency due to a partial gene deletion.
    Botto M; Fong KY; So AK; Barlow R; Routier R; Morley BJ; Walport MJ
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4957-61. PubMed ID: 1350678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of the complement C7 M/N polymorphism. A neutral amino acid substitution outside the epitope of the allospecific monoclonal antibody WU 4-15.
    Würzner R; Fernie BA; Jones AM; Lachmann PJ; Hobart MJ
    J Immunol; 1995 May; 154(9):4813-9. PubMed ID: 7722329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel polymorphism of human complement component C3 detected by means of a monoclonal antibody.
    Koch C; Behrendt N
    Immunogenetics; 1986; 23(5):322-5. PubMed ID: 3519446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited human complement C3 deficiency. An amino acid substitution in the beta-chain (ASP549 to ASN) impairs C3 secretion.
    Singer L; Whitehead WT; Akama H; Katz Y; Fishelson Z; Wetsel RA
    J Biol Chem; 1994 Nov; 269(45):28494-9. PubMed ID: 7961791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of hereditary C3 deficiency.
    Botto M; Fong KY; So AK; Rudge A; Walport MJ
    J Clin Invest; 1990 Oct; 86(4):1158-63. PubMed ID: 2212005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restriction fragment length polymorphism of the human C3 complement gene.
    Dandieu S; Lucotte G
    Exp Clin Immunogenet; 1986; 3(1):34-7. PubMed ID: 2908537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3 polymorphism in Kotas and Badagas of Nilgiri Hills, south India.
    Raj BK; Shankar V; Damodaran C; Sekharan PC
    Gene Geogr; 1988 Apr; 2(1):23-6. PubMed ID: 3154770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five restriction fragment length polymorphisms of the APOA1-C3 gene and their influence on lipids and apolipoproteins in healthy Chinese.
    Saha N; Tay JS; Low PS; Basair J; Hong S
    Hum Hered; 1995; 45(6):303-10. PubMed ID: 8537077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.